long-acting IL-11 analog (Bolder BioTechnology)

N/A

Report date: 2025/01/26 18:12:23

Base Information

Drug Namelong-acting IL-11 analog (Bolder BioTechnology)
Drug Alias Namelong-acting IL-11 analog (Bolder BioTechnology)
ClassificationBiologics
Mechanisms of ActionInterleukin-11 modulators
TargetsInterleukin-11
Therapy Area/IndicationsRadiation sicknessReperfusion InjuryRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesBolder Biotechnology
Inactive CompaniesN/A
Active IndicationsRadiation sickness
Inactive IndicationsReperfusion InjuryRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A